Skip to content

Drug interactions

Dasatinib + Levoketoconazole

Severity: Major

Dasatinib and Levoketoconazole: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Levoketoconazole is a strong CYP3A4 inhibitor and also prolongs the QT interval, and dasatinib is a CYP3A4 substrate that prolongs QT as well. Dasatinib exposure may rise substantially, increasing the risk of toxicity and arrhythmia.

What this interaction means in plain words

Dasatinib and Levoketoconazole can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Dasatinib belongs to Oncology; Levoketoconazole belongs to Endocrine.

Evidence level: High

Why it happens

Strong CYP3A4 inhibition reduces dasatinib clearance, with additive QT prolongation.

What to do

Avoid the combination. If it cannot be avoided, reduce the dasatinib dose per labeling for strong CYP3A4 inhibitors and monitor the ECG and for dasatinib adverse effects.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dasatinib and Levoketoconazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Dasatinib with Levoketoconazole?

MediHelp rates the interaction as major. Dasatinib and Levoketoconazole can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Levoketoconazole is a strong CYP3A4 inhibitor and also prolongs the QT interval, and dasatinib is a CYP3A4 substrate that prolongs QT as well. Dasatinib exposure may rise substantially, increasing the risk of toxicity and arrhythmia.

How serious is the interaction between Dasatinib and Levoketoconazole?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination. If it cannot be avoided, reduce the dasatinib dose per labeling for strong CYP3A4 inhibitors and monitor the ECG and for dasatinib adverse effects.

What other medicines interact with Dasatinib?

MediHelp also lists interactions of Dasatinib with, for example, Saquinavir, Thioridazine, Adagrasib. The full list is on the Dasatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in